The present study was designed to determine whether progesterone might have a role in gonadotrophininduced pituitary adenylate cyclase-activating polypeptide (Pacap) gene expression in rat ovary. Northern blot analysis revealed that treatment of pregnant mare's serum gonadotrophin (PMSG)-primed immature rats with the progestin antagonist RU486 or an inhibitor of 3β-hydroxysteroid dehydrogenase epostane, 1 h before HCG, resulted in a dose-dependent inhibition of the HCG-induced Pacap gene expression. In-situ hybridization demonstrated that the number of pre-ovulatory follicles expressing Pacap mRNA in their granulosa cells was greatly reduced in ovaries treated with RU486. Moreover, the suppressive effect of RU486 or epostane on the LH-induced Pacap gene expression in cultured pre-ovulatory follicles was reversed by cotreatment with the synthetic progestin R5020. We further cloned the 5Ј-flanking region of the rat Pacap gene and identified the presence of a consensus progesterone receptor element. When luciferase fusion genes containing Pacap gene promoter were transiently transfected into granulosa cells of pre-ovulatory follicles, luciferase activity was markedly stimulated by LH. Treatment with RU486 or epostane resulted in partial suppression of LH-stimulated PACAP promoter activity. Taken together, these results indicate that progesterone, acting through progesterone receptors, plays a role in gonadotrophin induction of Pacap gene expression in granulosa cells of pre-ovulatory follicles, and thereby may be involved in the process of ovulation. Key words: gonadotrophin/ovary/ovulation/Pacap/progesterone receptor Introduction (Clemens et al., 1998) . The induction of PR by LH has been suggested to be critical for progesterone action in regulating The pre-ovulatory surge of LH is obligatory to trigger ovulation, ovulation and activating specific genes. Inhibitors of progestera process by which pre-ovulatory follicles rupture, release a one biosynthesis and antiprogestin can block LH induction of fertilizable oocyte and undergo luteinization. Several studies ovulation in vivo (Tsafriri et al., 1987; Tanaka et al., 1992 ; have shown that the LH surge induces the rapid, but transient, Uilenbroek et al., 1992) . PR has also been shown to play a expression of specific genes associated with ovulation in functional role in the process of luteinization in vitro (Natraj and granulosa cells of pre-ovulatory follicles (Richards, 1994) . Richards, 1993) . Furthermore, a targeted deletion of the PR gene These specific genes induced by LH include the progesterone in mice causes the failure to ovulate even when exogenous receptor (PR) which is a member of the nuclear receptor gonadotrophins are administered (Lydon et al., 1995) , consuperfamily of transcription factors (Vegeto et al., 1993) and firming a key role for PR in the LH-induced process of ovulation. pituitary adenylate cyclase-activating polypeptide (PACAP), a However, target genes for PR action in the ovary have not yet novel neuropeptide with considerable homology to vasoactive been identified. intestinal peptide and growth hormone releasing hormone
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. The induction of PR by LH has been suggested to be critical for progesterone action in regulating The pre-ovulatory surge of LH is obligatory to trigger ovulation, ovulation and activating specific genes. Inhibitors of progestera process by which pre-ovulatory follicles rupture, release a one biosynthesis and antiprogestin can block LH induction of fertilizable oocyte and undergo luteinization. Several studies ovulation in vivo (Tsafriri et al., 1987; Tanaka et al., 1992 ; have shown that the LH surge induces the rapid, but transient, Uilenbroek et al., 1992) . PR has also been shown to play a expression of specific genes associated with ovulation in functional role in the process of luteinization in vitro (Natraj and granulosa cells of pre-ovulatory follicles (Richards, 1994) . Richards, 1993) . Furthermore, a targeted deletion of the PR gene These specific genes induced by LH include the progesterone in mice causes the failure to ovulate even when exogenous receptor (PR) which is a member of the nuclear receptor gonadotrophins are administered (Lydon et al., 1995) , consuperfamily of transcription factors (Vegeto et al., 1993) and firming a key role for PR in the LH-induced process of ovulation. pituitary adenylate cyclase-activating polypeptide (PACAP), a However, target genes for PR action in the ovary have not yet novel neuropeptide with considerable homology to vasoactive been identified. intestinal peptide and growth hormone releasing hormone
We have recently shown that gonadotrophins also induce (Arimura, 1992) .
the rapid and transient expression of Pacap mRNA in granulosa It has been shown that PR mRNA is transiently induced in cells of pre-ovulatory follicles by activating a cAMP-mediated granulosa cells of pre-ovulatory follicles by gonadotrophins in pathway (Lee et al., 1999) . Interestingly, the expression of the rat ovary (Park and Mayo, 1991; Natraj and Richards, Pacap mRNA appears to be delayed a few hours compared 1993). Several lines of evidence indicate that gonadowith that of PR mRNA after gonadotrophin stimulation (Park trophins activate the PR gene through a cAMP stimulation of and Mayo, 1991; Natraj and Richards, 1993; Lee et al. , the A-kinase pathway (Park-Sarge and Mayo, 1994; Park-Sarge 1999) , implying that PR may regulate Pacap gene expression. and Sarge, 1995) . Furthermore, recent study demonstrates that Furthermore, a recent report demonstrates that PACAP plays the phosphorylation of some transcription factors, in addition to a role in peri-ovulatory progesterone production and subsequent the oestrogen receptor, by gonadotrophin-activated the A-kinase luteinization in rat granulosa/lutein cells (Gräs et al., 1999) .
Thus, it appears plausible that one of the possible target genes pathway is critical for the transactivation of the PR gene for PR action in the ovary might be a PACAP. Based on these considerations, we have sought to determine whether progesterone, acting through PR, plays a role in gonadotrophin stimulation of Pacap gene expression in rat pre-ovulatory follicles. The present study shows that RU486, an antiprogestin, and epostane, an inhibitor of 3β-hydroxysteroid dehydrogenase, could block LH/HCG-induced Pacap gene expression in granulosa cells of pre-ovulatory follicles both in vivo and in vitro. We have also cloned the promoter region of the rat Pacap gene and examined the effect of RU486 or epostane on LHstimulated PACAP promoter activity in transfected granulosa cells.
Materials and methods

Hormones and reagents
Ovine LH (LH-S-26; 2 300 IU/mg) was obtained from the National Hormone and Pituitary Distribution Program, NIDDK, NIH (Baltimore, MD). HCG and pregnant mare's serum gonadotrophin (PMSG) were purchased from Sigma Chemical Co (St Louis, MO, USA). The progestin antagonist mifepristone (RU486) was purchased from Biomol Research Laboratories, Inc. (Plymouth Meeting, PA, USA). Inhibitor of 3β-hydroxysteroid dehydrogenase, epostane (2α,4α,17-4,5-epoxy-17-hydroxy-4,17-dimethyl-3-oxoandrostane-2-carbonitrile), was provided by the courtesy of Dr B.W.Snyder (Sterling-Winthrop, New York, NY, USA). The synthetic progestin R5020 (17,21-dimethyl-19-nor-4,9-pregnadiene-3,20 dione) was the generous gift of Dr J.P.Raynaud (Roussel-UCLAF, Romainville, France).
Animals
Immature female rats of the Sprague-Dawley strain were purchased from Daehan Laboratories (Chungbuk, Korea). They were housed in groups in a room with controlled temperature and photoperiod (10 h Figure 1 . Inhibition of HCG-induced Pacap gene expression by darkness/14 h light, with lights on from 06:00-20:00 h). The animals mifeprostone (RU486) or epostane in pregnant mare's serum had access to food and water ad libitum. At 26 days old, the animals gonadotrophin (PMSG)-primed immature rat ovaries. (A) PMSGprimed immature rats were injected i.p., 1 h before HCG, with (body weight, 60-65 g) were injected s.c. with 10 IU PMSG to different doses (mg/rat) of RU486 or epostane. Total RNA was induce multiple follicle growth. After 48-52 h, the animals were extracted from ovaries collected before HCG; (C) 6 h after HCG killed by cervical dislocation and the ovaries were removed for (HCG) and HCG plus RU486 (RU) or epostane (epo). Total follicle dissection or granulosa cell collection. Some rats received ovarian RNA (20 µg) was analysed by Northern blotting using a i.p. administration of RU486 or epostane, 1 h before 10 IU HCG cDNA probe for rat PACAP. Arrowheads indicate the position of injection to induce ovulation, and ovaries were obtained 6 h after PACAP transcripts. (B) Quantification of data in (A). The 3 kb stimulation for Northern blot and in situ hybridization analysis.
PACAP transcript was quantified using a phosphorimager and normalized for 28S ribosomal RNA levels in each sample. Results
Northern blot analysis
are expressed relative to ovarian PACAP mRNA levels found at 6 h after HCG stimulation. Each data point represents the mean Ϯ Total RNA from ovaries or cultured follicles was isolated using Tri SEM from three independently performed experiments. Reagent solution (Sigma Chemical Co). Total RNA (10-20 µg) were *Significantly different (P Ͻ 0.05) compared with the value fractionated by electrophoresis on a 1% agarose gel containing observed in ovaries treated with HCG. formaldehyde and were transferred to nylon membranes by capillary blotting with 10ϫ sodium citrate/sodium chloride (SSC). After
In-situ hybridization analysis UV cross-linking and prehybridization, membranes were hybridized overnight at 42°C in a solution containing 50% formamide, 5ϫ SSC, Ovaries were fixed at 4°C for 6 h in 4% paraformaldehyde in PBS, followed by immersion in 0.5 M sucrose in PBS overnight. Cryostat 1 mmol/l EDTA, 250 µg/ml denatured salmon sperm DNA, 500 µg/ ml yeast transfer RNA, and a total of 2-4ϫ10 6 cpm of a [ 32 P]-sections (14-µm thick) were mounted on poly-L-lysine (Sigma Chemical Co)-coated microscope slides, fixed in 4% paraformallabelled full-length rat Pacap complementary DNA (cDNA) probe (Lee et al., 1999) . After hybridization, membranes were washed twice dehyde in PBS, and stored at -80°C until analysed. The hybridization procedure was essentially the same as previously described (Lee for 5 min at room temperature in 2ϫ SSC and 0.1 sodium dodecyl sulphate (SDS), followed by 1 h at 65°C in 0.5ϫ SSC and 0.1% et al., 1999) . In brief, sections were pretreated serially with 0.2 mol/ l HCl, 2ϫ SSC, pronase (0.125 mg/ml), 4% paraformaldehyde, and SDS. Membranes were then exposed using Kodak RX films (Eastman Kodak Co, Rochester, NY, USA) for 1-3 days at -80°C. The signals acetic anhydride in triethanolamine. Hybridization was carried out at 52-55°C overnight in the mixture containing [ 35 S]-labelled rat Pacap were normalized to the 28S ribosomal RNA internal control. cRNA probe (10 8 cpm/ml), 50% formamide, 0.3 mol/l NaCl, 10 untranslated region of rat Pacap cDNA (Ogi et al., 1990 ) which corresponds to the exon 1B of the mouse Pacap gene (Yamamoto mmol/l Tris-HCl, 5 mmol/l EDTA, 1ϫ Denhardt's solution, 10% dextran sulphate, 1 µg/ml carrier transfer RNA, and 10 mmol/l et al., 1998). The nested PCR was then performed using the diluted primary PCR reaction mixture as a template, the nested adaptor dithiothreitol. Post-hybridization washing was performed under stringent conditions that included ribonuclease A (25 µg/ml) treatment at primer, and the nested gene-specific primer (5Ј-GGGGGACTTGTTT-GCCGAAGCTAAAATTCC-3Ј). The PCR conditions for denatura-37°C for 30 min and a final stringency of 0.1ϫ SSC. Slides were dipped into NTB-2 emulsion (Eastman Kodak Co) and exposed at tion, annealing, and elongation for the first seven cycles were 94, 72, and 72°C for 25 s, 4 min and 4 min respectively, and for the 4°C until being developed after 2 weeks. The slides were stained with haematoxylin and eosin and were examined under the light subsequent 32 cycles were 94, 67, and 67°C for 25 s, 4 min, and 4 min respectively. Three overlapping PCR clones were identified microscope with bright-and dark-field illumination.
and subcloned into the pGEM-T vector (Promega Corporation,
Follicle culture
Madison, WI, USA). The DNA sequence was determined by the dideoxy chain termination method using a sequencing kit (Amersham, Pre-ovulatory follicles (Ͼ800 µm in diameter) were isolated from ovaries collected at 48-52 h after PMSG injection, and follicle culture Arlington Heights, IL, USA) and a DNA sequencer (Perkin-Elmer, Foster City, CA, USA). was performed as previously described (Lee et al., 1999) . were cultured in glass vials containing 800 µl Eagle's Granulosa cell culture, transfection, and luciferase assays minimal essential medium (MEM) (Gibco, Grand Island, NY, USA) supplemented with penicillin, streptomycin, L-glutamine, and 0.1% Granulosa cells collected from pre-ovulatory follicles of PMSGprimed immature rat ovaries were cultured as described (Park-Sarge BSA (wt/vol, Fraction V, Sigma Chemical Co) in the absence or presence of different hormones. Cultures were maintained in serumand Mayo, 1994) at a density of 0.5-1ϫ10 6 cells per 2.5 ml of Dulbecco's modified Eagle's medium/F12 (DMEM/F12) medium free conditions for up to 24 h at 37°C under 5% CO 2 -95% O 2 . At the end of incubation, follicles were snap-frozen for RNA isolation.
supplemented with 10% fetal bovine serum (FBS; Gibco) in multiwell (60 mm) dishes in a humidified incubator at 37°C and 5% CO 2 .
Cloning of rat PACAP promoter
Granulosa cells were transiently transfected within 2 h after plating using a calcium phosphate precipitation method (Park-Sarge and Cloning of rat PACAP promoter region was performed according to the manufacturer's instructions using GenomeWalker Kits (Clontech Mayo, 1994) and 8 µg plasmid/well. To evaluate promoter activity, the 5Ј-flanking sequence (-1475 to -1 bp) of the rat PACAP promoter Laboratories Inc, Palo Alto, CA, USA). Briefly, the templates used for polymerase chain reaction (PCR) were five different genomic was ligated to pGL3 basic luciferase vector (pGL3-Luc; Promega Corporation) and named as PACAP-Luc. The plasmid DNA used for libraries of uncloned, adaptor-ligated DNA fragments provided in the kit. The primary PCR was performed with the template, genomic transfection contained PACAP-Luc, a fixed amount of pCMV-β-galactosidase and a promoterless pGL3-Luc. After transfection for polymerase mix, the outer adaptor primer provided in the kit, and the gene-specific primer (5Ј-CGCTGGAATCACAACCAGAGAGG-15-20 h, the cells were washed and cultured in serum-free DMEM/ F12 medium in the absence or presence of LH (200 ng/ml) with or CATCAG-3Ј). The gene-specific primer was derived from the 5Ј-
Results
Effect of RU486 or epostane on gonadotrophininduced Pacap gene expression in PMSG/HCGtreated rat ovaries
To study the role of progesterone in gonadotrophin-induced Pacap gene expression, the progestin antagonist RU486 or an inhibitor of 3β-hydroxysteroid dehydrogenase epostane was administered 1 h before HCG stimulation in PMSG-primed immature rats. Northern blot analysis of total ovarian RNA revealed the marked induction of Pacap mRNA 6 h after HCG stimulation ( Figure 1A ) as previously reported (Lee et al., 1999) . Treatment with either RU486 (RU) or epostane (epo) suppressed the HCG-induced Pacap mRNA expression in a dose-dependent manner. Quantification of data, using the upper 3 kb PACAP transcript, showed 65% inhibition of HCGstimulated Pacap mRNA values by RU486 or epostane at the maximal dose ( Figure 1B ) that effectively blocked ovulation. Quantification of the lower two transcripts (1.2 and 2.4 kb), showed the same levels of the inhibition by RU486 or epostane (data not shown).
To determine the cell types expressing Pacap mRNA after RU486 treatment, antisense and sense cRNA probes for Pacap were generated for in-situ hybridization analysis. In ovaries of PMSG-primed immature rats followed by HCG stimulation for 6 h, high levels of Pacap mRNA were detected in all preovulatory follicles (Figure 2A,B) (Lee et al., 1999) . However, in ovaries of PMSG/HCG-stimulated immature rats treated with RU486, 1 h before HCG, at a dose that effectively blocked ovulation (Tsafriri et al., 1987) , the number of preovulatory follicles expressing Pacap mRNA was greatly reduced (Figure 2C,D) . Furthermore, treatment with RU486 resulted in the inhibition of Pacap mRNA expression in granulosa cells of pre-ovulatory follicles, but not in theca/ synthetic progestin R5020, pre-ovulatory follicles obtained from ovaries of rats primed for 2 days with PMSG were without 10 -5 mol/l RU486 or epostane for 7 h. The cells were then incubated in serum-free conditions in the presence of hormones. lysed in a buffer containing 1% Triton X-100, 25 mM HEPES, Increasing amounts of R5020 (0.5-50 µmol/l) were added to pH 7.8, 15 mmol/l MgSO 4 , 2 mmol/l EGTA, pH 8.0. Aliquots of follicle cultures containing 200 ng/ml LH and 10 -5 mol/l the supernatant were analysed for β-galactosidase and luciferase RU486 or epostane, and levels of Pacap mRNA expression activities. For luciferase assays, the cell lysates (20 µl) were added were analysed after 7 h by Northern blot analysis. Treatment to 100 µl of assay buffer (25 mmol/l HEPES, pH 7.8, 15 mmol/l MgSO 4 , 5 mmol/l ATP, 1 µg/ml BSA), and 20 µl of 1 mmol/l of pre-ovulatory follicles with either RU486 ( Figure 3A ) or luciferin (Promega Corporation) was added using an automatic epostane ( Figure 3B ) suppressed the LH-stimulated Pacap injector; emitted luminescence was measured using a LB9501 mRNA expression by 60% (n ϭ 2). Inclusion of R5020 caused luminometer (Berthold, Germany) for 10 s. All data were corrected a reversal of the inhibitory effect of RU486 ( Figure 3A ) or for the β-galactosidase activity in each dish. epostane ( Figure 3B ) on LH-induced Pacap mRNA expression. At 50 µmol/l R5020, the inhibitory effect of RU486 and Data analysis epostane was completely reversed to the levels of LH-treated Statistical differences were assessed by one-way analysis of variance follicles. Treatment of follicles with R5020 alone had no effect (ANOVA), followed by Student's t test; and P Ͻ 0.05 was considered to be statistically significant. on the expression of Pacap mRNA. 
Identification of a consensus progesterone response
(TRE), and two growth hormone factor-1 (GHF-1) binding sites. In addition, a potential TATA box and PRE which shows element (PRE) in the rat PACAP promoter 75% homology to the consensus sequence of PRE (Beato To examine further the molecular mechanisms by which et al., 1989) was identified in the 5Ј-flanking region of the rat progesterone regulates the LH-stimulated Pacap gene expresPacap gene. sion, genomic clones containing the 5Ј-portion of the rat Pacap gene were isolated by PCR using rat genomic libraries as a Effect of RU486 or epostane on gonadotrophintemplate. Three overlapping PCR clones were identified and stimulated PACAP promoter activity in transfected sequenced. Figure 4 shows that the alignment of the 5Ј-portion granulosa cells of the rat and mouse Pacap genes (Yamamoto et al., 1998) revealed a high degree of sequence similarity (90%) including As a complementary approach and more direct way to assess the effect of progesterone on LH-stimulated Pacap gene exon 1A, intron 1, exon 1B, and the 5Ј-flanking region. The 5Ј-flanking region of both rat and mouse Pacap genes contained expression, we analysed hormone-induced Pacap promoter activity in transfected granulosa cells. Granulosa cells obtained several consensus elements reminiscent of some well-conserved consensus motifs involved in transcriptional control:
from pre-ovulatory follicles were transiently transfected with a fusion gene (PACAP-Luc), containing the 5Ј-flanking region two cAMP response elements (CRE), a TPA response element ovulatory follicles in the rat ovary, indicating that Pacap may be one of the target genes for PR action in the ovary. We previously observed the transient induction of Pacap mRNA by LH/HCG in granulosa cells of pre-ovulatory follicles (Lee et al., 1999) . This gonadotrophin-induced Pacap mRNA expression in pre-ovulatory follicles was abolished by an antiprogestin RU486 both in vivo and in vitro, indicating the regulation of gonadotrophin-induced Pacap gene expression by progesterone. RU486 has been shown to antagonize progestin action by binding to PR and causing a conformational change in PR (Gass et al., 1998) . Likewise, an inhibitor of progesterone biosynthesis, epostane, also inhibited the gonadotrophininduced Pacap gene expression, suggesting that progesterone, acting through PR, plays a role in regulating Pacap gene for progesterone in ovulation (Bullock and Kappauf, 1972;  between individual experiments, luciferase activity in cell lysates is normalized to that observed in cells transfected with PACAP-Luc Holmes et al., 1985) , evidence has been accumulating to and incubated in the absence of any hormones (C), and is presented document that progesterone is critical for regulating ovulation as the fold increase compared with this value. Luciferase activities (Rondell, 1974) and luteinization (Rothchild, 1981) in the rat.
in cells transfected with negative control promoterless vector Inhibitors of progesterone biosynthesis, such as epostane (pGL3-Luc) and incubated in the absence of hormones were not (Tsafriri et al., 1987; Espey et al., 1990; Tanaka et al., 1992) significantly different from those observed in cells transfected with PACAP-Luc and incubated in the absence of any hormones (data and aminoglutethimide (Lipner and Greep, 1971) , can block not shown). Each data point represents the mean Ϯ SEM of three LH induction of ovulation in vivo. Moreover, the administration independent experiments with triplicate determinations in each of the antiprogestin RU486 in vivo has been shown to block experiment. *Significantly different (P Ͻ 0.05) compared with the ovulation (Tsafriri et al., 1987; Uilenbroek et al., 1992) . These value observed in cells treated with LH. data indicate that progesterone, acting through PR, may play a role in the regulation of ovulation. Recent evidence for the of the rat Pacap gene ligated to the luciferase reporter gene, presence of PR in the ovary has added credence to the action along with an internal control (pCMV-β-gal) for transfection of this steroid in regulating ovulation. PR mRNA is transiently efficiency and a promoterless parental luciferase vector (pGL3-induced in granulosa cells of pre-ovulatory follicles after the Luc). Treatment of the transfected granulosa cells with LH LH surge, but not in granulosa cells of pre-ovulatory follicles resulted in 7.7-fold increase in luciferase activity compared before the LH surge in the rat (Park and Mayo, 1991) . The with that observed in cells transfected with PACAP-Luc and fact that PR is only present transiently after the LH surge incubated in the absence of any hormones ( Figure 5 ). Cosuggests that any specific receptor-mediated effects of progestreatment with RU486 (RU) or epostane (epo) partially supterone on granulosa cells would have to occur during this pressed the stimulatory effect of LH on luciferase activity.
period. PR mRNA was observed in detectable amounts by 2 h, Treatment of these cells with RU486 or epostane alone had reached a peak at 4-5 h, and declined by 8 h in rat granulosa no effect on luciferase activity. Luciferase activity was not cells of pre-ovulatory follicles (Park and Mayo, 1991 ; Natraj affected by any of these hormonal treatments in cells transfected and Richards, 1993) . Similar pattern of transient expression with negative control promoterless vector, pGL3-Luc (data after LH/HCG has been observed in Pacap gene expression not shown).
in the rat ovary (Gräs et al., 1996; Lee et al., 1999) . The induction of Pacap mRNA in granulosa cells of pre-ovulatory Discussion follicles after gonadotrophin stimulation, however, appears to be delayed for a few hours, compared with that of PR mRNA; Although the induction of progesterone and PR by the LH surge has been suggested to play a role in activating specific it was detected by 3 h, reached a peak by 6-9 h, and declined by 12 h (Lee et al., 1999) . In addition, the induction of both genes and thus regulating ovulation, target genes for PR action in the ovary have not been identified. Our results indicate that PR and Pacap mRNA requires the same gonadotrophinactivated a cAMP-protein kinase A pathway (Park-Sarge and progesterone, acting through PR, plays a role in LH/HCGinduced Pacap gene expression in granulosa cells of preMayo, 1994; Lee et al., 1999) , suggesting that progesterone, acting through PR, may regulate Pacap gene expression. Such or epostane of the LH-stimulated PACAP promoter activity suggests that LH may induce Pacap gene expression by a view is supported by the present finding that treatment of PMSG-primed immature rats with RU486 or epostane partially activating other pathway(s) in addition to the PR. Indeed, blockade of phospholipase A 2 pathway has also been shown inhibited gonadotrophin-induced ovarian Pacap gene expression in granulosa cells of pre-ovulatory follicles. In addition, to inhibit the LH induction of Pacap gene expression in preovulatory follicles (our own observations). Alternatively, the the synthetic progestin R5020 could reverse the inhibitory effect of RU486 or epostane on Pacap gene expression in present observation that RU486 blocked Pacap gene expression in some but not all follicles raises the possibility that PR cultured pre-ovulatory follicles, further supporting the role of progesterone, acting through PR, in regulating Pacap gene activation may be only an indirect mediator leading to transcriptional activation of the PACAP promoter, and may need the expression. The present observation that RU486 treatment, at a dose that effectively blocked ovulation (Tsafriri et al., 1987) , interaction with specific co-factors. Indeed, recent studies suggest that the altered conformation in PR induced by resulted in a partial inhibition of Pacap gene expression by reducing the number of pre-ovulatory follicles expressing antagonists impairs the ability of receptors to interact with coactivator (Smith et al., 1996) . Overexpression of the PR protein Pacap mRNA in their granulosa cells, raises the possibility that only those pre-ovulatory follicles expressing Pacap mRNA in the transfected HeLa cells did not affect the promoter activities of the Pacap gene (our own observations), suggesting in their granulosa cells after RU486 treatment may eventually ovulate. If such a possibility exists, it appears plausible that that different cell types contain different levels of specific coactivators or co-repressors necessary for PR action (Kraus PR plays a role in the process of ovulation by regulating Pacap gene expression. Thus, one major question that remains et al., 1993, 1994) . It has been suggested that the relative amounts of co-activators and co-repressors may contribute to to be answered is whether PACAP is critical for regulating ovulation. Our recent observation, demonstrating the transient the partial agonist or antagonist activity of a ligand (Jackson et al., 1997; Smith et al., 1997) . expression of Pacap type I receptor mRNA in granulosa cells of pre-ovulatory follicles after LH/HCG (Park et al., 2000) ,
In summary, this study shows that progesterone, acting through PR, plays a role in gonadotrophin-stimulated Pacap supports the possible role of PACAP in the process of ovulation as an autocrine factor. Interestingly, PR gene knock-out mice gene expression in granulosa cells of rat pre-ovulatory follicles.
Whether PR plays a role in the process of ovulation by exhibit the failure to ovulate even when exogenous gonadotrophins are administered (Lydon et al., 1995) . It would be regulating Pacap gene expression remains to be clarified. of interest to test the Pacap gene expression and whether administration of gonadotrophins together with PACAP would
